Likes Subject
What we are missing is a good CEO!
J G R 12/08/22 9:39 PM
Thank you! Reading these, it's inconceivable/inexplicable as to fantomphan 12/08/22 8:33 AM
Case of the Week 41 andy55q 12/08/22 7:41 AM
Case of the Week andy55q 12/08/22 7:38 AM
based on the 5 year chart, I would dr_lowenstein 12/07/22 7:38 PM
been a while. thought i would check in. dr_lowenstein 12/07/22 7:36 PM
Andy, where are you with the cases? Give fantomphan 12/07/22 9:15 AM
They can announce all they want shareholders are Harbor6460 11/21/22 1:27 PM
NEWS -- CytoSorbents Announces Pivotal STAR-T Trial Reaches Paulness 11/14/22 8:29 AM
Up a penny AH on Friday to $1.53. fantomphan 11/13/22 9:41 AM
Chan 15 years of tech wasted. My god. Harbor6460 11/09/22 12:01 PM
Biotech48, Of course you must be joking. I Cytobeliever 11/07/22 5:46 PM
Cyto believer, I am surprised that you have biotech48 11/06/22 4:52 PM
I am sorry to say that I Cytobeliever 11/04/22 11:39 AM
Looks like the market just loves this management fantomphan 11/04/22 8:27 AM
Q3 2022 Results & Webcast 4:30pm dial Good Sport 11/03/22 4:22 PM
'Enhanced Lung Rest' with CytoSorb and ECMO Achieves Good Sport 11/02/22 12:02 PM
Update on CytoSorb® therapy in liver dysfunction / Good Sport 11/01/22 4:16 PM
bt48, did you happen to follow up on kjpcrna 10/31/22 7:31 PM
Why is she bailing out before a replacement ranchhand71 10/31/22 6:10 PM
lLnk to Dawson James Research recent CTSO report: ranchhand71 10/31/22 6:08 PM
NEWS -- National Institutes of Health Grants Phase Paulness 10/31/22 9:17 AM
Case of the Week andy55q 10/19/22 7:36 AM
Thanks Andy, the device seems to be working well. biotech48 10/18/22 4:04 PM
A New Apheresis Device for Antithrombotic Drug Removal andy55q 10/17/22 8:32 AM
CytoSorbents Reports New Cardiac Surgery Data with CytoSorb Good Sport 10/12/22 8:54 AM
Use of CytoSorb© Hemoadsorption in Patients on Veno-Venous Good Sport 10/11/22 9:33 AM
So now Google Jason Kolbert of Dawson James. fantomphan 10/11/22 7:55 AM
That's one inept incompetent down, several more to fantomphan 10/07/22 9:20 AM
NEWS -- CytoSorbents Announces Pending Retirement of Chief Paulness 10/07/22 8:17 AM
8-K just filed, "retire from her role Good Sport 10/06/22 7:35 PM
CytoSorbents Awarded an Approximately $4.3M Contract by the Good Sport 10/06/22 4:06 PM
Because we have an academic/MD for a CEO. GeicoGecko 10/05/22 6:01 PM
This kid was a mess. That the CTSO fantomphan 10/05/22 9:48 AM
Case of the Week andy55q 10/05/22 8:01 AM
Google this guy Sean Lee. His record and fantomphan 09/28/22 5:18 PM
H.C. Wainwright Reaffirms Their Buy Rating on Cytosorbents (CTSO) Good Sport 09/28/22 3:11 PM
My Cousin Vinny quoted in the PR! How fantomphan 09/27/22 9:30 AM
NEWS -- CytoSorbents Achieves ISO 13485 Certification of Paulness 09/27/22 9:06 AM
Less than 0.05 cents presplit! eskay1954 09/26/22 1:00 PM
Any cheerleaders with pom poms “backing up the kjpcrna 09/22/22 1:56 PM
CEO just made a sizable insider buy of io_io 09/12/22 1:18 PM
The U.S. Department of Defense Awards CytoSorbents an Good Sport 09/09/22 9:11 AM
The timeline, cost, and impact of those FDA Jdizzy 09/08/22 6:13 PM
Bio, your optimism is admirable (and genuine I fantomphan 09/07/22 7:45 AM
fantomphan, the ship has a rudder and is biotech48 09/07/22 12:48 AM
This is a rudderless ship with these incompetents fantomphan 09/06/22 10:25 AM
Case report: Cytokine hemoadsorption in a case of andy55q 09/02/22 7:27 AM
New on PubMed andy55q 08/31/22 8:02 AM
Eskay, on 4/6/20 you posted what you said biotech48 08/28/22 11:51 PM
Likes Subject

12/08/22 9:39 PM
12/08/22 7:41 AM
12/08/22 7:38 AM
12/07/22 7:38 PM
12/07/22 7:36 PM
12/07/22 9:15 AM
11/21/22 1:27 PM
11/13/22 9:41 AM
11/09/22 12:01 PM
11/07/22 5:46 PM
11/06/22 4:52 PM
11/04/22 11:39 AM
Good Sport
11/03/22 4:22 PM
10/31/22 7:31 PM
10/31/22 6:10 PM
10/19/22 7:36 AM
10/11/22 7:55 AM
Good Sport
10/06/22 7:35 PM
10/05/22 6:01 PM
10/05/22 9:48 AM
10/05/22 8:01 AM
09/28/22 5:18 PM
09/27/22 9:30 AM
09/26/22 1:00 PM
09/07/22 12:48 AM
08/31/22 8:02 AM
08/28/22 11:51 PM

Cytosorbents Corporation (CTSO)

Posts (Today)
Posts (Total)
Moderators Good Sport
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 68 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents recently initiated its pivotal REFRESH (REduction in FREe Hemoglobin) 2 trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 46,000 human treatments to date. 

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $22 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites at and or follow us on Facebook and Twitter.

Most Liked Posts
(Last 30 Days)
New Post